$0.4721
-0.0979-17.18%
Dern. MÀJ: Nov 13, 3:32 PM
Basel Medical fell 96.3% from $15.48 to $0.57, behind the S&P 500's +12.7%. Its worst day was Nov 11 (−64.6%), and its low came Nov 12 at $0.57.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-6.07 was reported on $8.9M revenue.
+1.8% · S&P 500 −0.8%
Basel Medical shares rose 30.9%, while the S&P 500 fell 1.1%.
+30.9% · S&P 500 −1.1%
Story events cover the past 12 months · Times ET
Basel Medical shares rose 25.9%, while the S&P 500 fell 1.4%.
+25.9% · S&P 500 −1.4%
Basel Medical shares fell 26.1%, while the S&P 500 rose 0.4%.
−26.1% · S&P 500 +0.4%
EPS of $0.01 was reported on $6.4M revenue.
+2.4% · S&P 500 −0.7%
Basel Medical shares rose 32.2%, while the S&P 500 rose 0.4%.
+32.2% · S&P 500 +0.4%
Basel Medical shares rose 30.7%, while the S&P 500 rose 0.0%.
+30.7% · S&P 500 0.0%
Basel Medical shares rose 54.7%, while the S&P 500 fell 0.4%.
+54.7%, the year's best day, on 32M shares, the year's heaviest volume · S&P 500 −0.4%
Where it ended: a close of $0.57 on Nov 12, 2026.
Nothing in the past 12 months.
All BMGL analyst actionsNothing in the past 12 months.
All BMGL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BMGL and SPY from Benzinga historical bars. Not investment advice.